<DOC>
	<DOC>NCT02097329</DOC>
	<brief_summary>To investigate the effect of acid reducing agents (an antacid and an H2-receptor antagonist and a proton pump inhibitor) on palbociclib bioavailability in the presence of food.</brief_summary>
	<brief_title>Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food</brief_title>
	<detailed_description />
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<mesh_term>Anti-Ulcer Agents</mesh_term>
	<mesh_term>Palbociclib</mesh_term>
	<mesh_term>Antacids</mesh_term>
	<criteria>Healthy male and/or female subjects of nonchildbearing potential between the ages of 18 and 55 years, inclusive. Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight &gt;50 kg (110 lbs). Willing and able to comply with all scheduled visits, treatment plan, laboratory tests, and other study procedures. Evidence or history of clinically significant diseases (hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease). Use of tobacco or nicotine containing products within 3 months of screening. A positive urine drug screen.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>bioavailability</keyword>
	<keyword>antacid</keyword>
	<keyword>rabeprazole</keyword>
	<keyword>famotidine</keyword>
	<keyword>palbociclib</keyword>
</DOC>